Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab
Description
CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that immunization with inactivated vaccines during natalizumab therapy was both safe and immunogenic, regardless of the treatment duration. Natalizumab may be a valuable option for
